Detalhe da pesquisa
1.
Macrophage migration inhibitory factor in lung tissue of idiopathic pulmonary fibrosis patients.
Exp Lung Res
; 42(5): 263-6, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27337548
2.
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma.
BMC Cancer
; 15: 374, 2015 May 08.
Artigo
Inglês
| MEDLINE | ID: mdl-25952930
3.
miRNAs Potentially Involved in Post Lung Transplant-Obliterative Bronchiolitis: The Role of miR-21-5p.
Cells
; 10(3)2021 03 20.
Artigo
Inglês
| MEDLINE | ID: mdl-33804639
4.
Peripheral CD19+CD24highCD38high B-regulatory cells in lung transplant recipients.
Transpl Immunol
; 57: 101245, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31526864
5.
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study.
Int J Nanomedicine
; 14: 773-785, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30774332
6.
5-hydroxymethylcytosine but not MTAP methylation status can stratify malignant pleural mesothelioma based on the lineage of origin.
Multidiscip Respir Med
; 13: 27, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30123503
7.
Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents.
Nanotoxicology
; 11(4): 534-545, 2017 May.
Artigo
Inglês
| MEDLINE | ID: mdl-28415888
8.
Identification of miRNAs Potentially Involved in Bronchiolitis Obliterans Syndrome: A Computational Study.
PLoS One
; 11(8): e0161771, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27564214
9.
Unexpected responses to EGFR inhibition in NSCLC.
Respir Med Case Rep
; 16: 32-4, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26744648
10.
Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction.
Nanomedicine (Lond)
; 10(1): 9-23, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24559038
11.
Activation of oncogenic pathways in idiopathic pulmonary fibrosis.
Transl Oncol
; 7(5): 650-5, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-24935008
12.
Non-neuronal cholinergic system in airways and lung cancer susceptibility.
Transl Lung Cancer Res
; 2(4): 284-94, 2013 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25806244
13.
EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells.
J Cancer Res Clin Oncol
; 139(8): 1327-35, 2013 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-23644698
14.
Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma.
J Thorac Oncol
; 8(4): 469-77, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23486267
15.
MET genetic lesions in non-small-cell lung cancer: pharmacological and clinical implications.
Transl Lung Cancer Res
; 1(3): 194-207, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-25806181
16.
Targeting EGFR in non-small-cell lung cancer: lessons, experiences, strategies.
Respir Med
; 106(2): 173-83, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-22104541
17.
Large-cell lung carcinoma with basaloid architecture and neuroendocrine differentiation: a new type of combined large-cell neuroendocrine carcinoma.
Int J Surg Pathol
; 19(2): 252-8, 2011 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-21131317
18.
Incomplete expression of epithelial-mesenchymal transition markers in idiopathic pulmonary fibrosis.
Pathol Res Pract
; 207(9): 559-67, 2011 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-21798671
19.
Synchronous lung cancers: when same histological types feature different molecular profiles and response phenotypes.
J Cancer
; 2: 474-7, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-21980321
20.
Factors influencing oxidative imbalance in pulmonary fibrosis: an immunohistochemical study.
Pulm Med
; 2011: 421409, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-21660236